Although not statistically significant, the values of IgA anti-β2GPI were markedly elevated in patients with thrombosis compared to patients without thrombosis (30.6 ± 82.3 IU/mL vs. 8.5 ± 40.9 IU/mL) (Figure 1). This evidence concerns the gene CD79A and Venous thrombosis.